Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$5.67 - $11.2 $396,900 - $784,000
70,000 New
70,000 $572,000
Q3 2021

Nov 15, 2021

SELL
$24.86 - $35.02 $11.3 Million - $16 Million
-456,300 Reduced 91.26%
43,700 $50,000
Q1 2019

May 15, 2019

SELL
$6.8 - $7.4 $9.59 Million - $10.4 Million
-1,409,600 Reduced 73.82%
500,000 $13,000
Q4 2018

Feb 14, 2019

BUY
$3.99 - $7.82 $7.42 Million - $14.5 Million
1,859,600 Added 3719.2%
1,909,600 $281,000
Q3 2018

Nov 14, 2018

BUY
$3.52 - $5.55 $176,000 - $277,500
50,000 New
50,000 $46,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $288M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Oracle Investment Management Inc Portfolio

Follow Oracle Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oracle Investment Management Inc with notifications on news.